Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Argus Health
Dow
Queensland Health
McKinsey
Merck
Fish and Richardson
Cerilliant

Generated: July 17, 2018

DrugPatentWatch Database Preview

Caffeine; ergotamine tartrate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for caffeine; ergotamine tartrate and what is the scope of caffeine; ergotamine tartrate freedom to operate?

Caffeine; ergotamine tartrate
is the generic ingredient in four branded drugs marketed by Novartis, Horizon Pharma, Sandoz, Hikma Intl Pharms, Mikart, and Organon Usa Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for caffeine; ergotamine tartrate. Seven suppliers are listed for this compound.
Summary for caffeine; ergotamine tartrate
Pharmacology for caffeine; ergotamine tartrate
Synonyms for caffeine; ergotamine tartrate
C33H35N5O5.C8H10N4O2.C4H6O6
LS-178495
SCHEMBL8529932

US Patents and Regulatory Information for caffeine; ergotamine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Horizon Pharma MIGERGOT caffeine; ergotamine tartrate SUPPOSITORY;RECTAL 086557-001 Oct 4, 1983 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Organon Usa Inc WIGRAINE caffeine; ergotamine tartrate TABLET;ORAL 086562-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Intl Pharms ERGOTAMINE TARTRATE AND CAFFEINE caffeine; ergotamine tartrate TABLET;ORAL 040510-001 Sep 17, 2004 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mikart ERGOTAMINE TARTRATE AND CAFFEINE caffeine; ergotamine tartrate TABLET;ORAL 040590-001 Sep 16, 2005 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Boehringer Ingelheim
Federal Trade Commission
Daiichi Sankyo
Teva
QuintilesIMS
Dow
Chinese Patent Office
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.